Blood pressure and kidney update 2016/2017

The most important studies – from randomized controlled trials to perspective studies and meta-analyses, and guidelines in the topics of blood pressure and kidney research published in 2016 (and at the beginning of 2017) were reviewed. In the blood pressure area, the most important were the Systolic Blood Pressure Intervention Trial (SPRINT), which might have a great impact on the clinical practice as well as on the forthcoming guidelines, including the US recommendations recently published. Similarly important was the Heart Outcomes Prevention Evaluation (HOPE)-3 trial, which clearly confirmed that only combination therapy with antihypertensive drugs and statins might be effective in prevention of cardiovascular outcomes in patients at high risk of cardiovascular disease events. The research on kidney diseases was very interesting and extensive in 2016, and we have tried to present the most important data from the following areas: glomerulopathies, diabetic nephropathy, lupus nephritis, acute kidney injury, chronic kidney disease – risk factors, management and complications, and hemodialysis.